FDAnews Drug Daily Bulletin

Transcept Strikes Home on Third Try for Insomnia Drug Intermezzo

Dec. 12, 2011
A A
The FDA has approved Transcept Pharmaceuticals’ insomnia drug Intermezzo on its third NDA attempt that followed two complete response letters.
Washington Drug Letter